Shanghai Medicilon Inc.

SHSE:688202 Stock Report

Market Cap: CN¥4.3b

Shanghai Medicilon Balance Sheet Health

Financial Health criteria checks 3/6

Shanghai Medicilon has a total shareholder equity of CN¥2.4B and total debt of CN¥265.6M, which brings its debt-to-equity ratio to 11.3%. Its total assets and total liabilities are CN¥2.9B and CN¥596.3M respectively.

Key information

11.3%

Debt to equity ratio

CN¥265.62m

Debt

Interest coverage ration/a
CashCN¥654.89m
EquityCN¥2.35b
Total liabilitiesCN¥596.33m
Total assetsCN¥2.95b

Recent financial health updates

Recent updates

Shanghai Medicilon Inc. (SHSE:688202) Might Not Be As Mispriced As It Looks

Sep 27
Shanghai Medicilon Inc. (SHSE:688202) Might Not Be As Mispriced As It Looks

Is Shanghai Medicilon (SHSE:688202) Weighed On By Its Debt Load?

Jun 07
Is Shanghai Medicilon (SHSE:688202) Weighed On By Its Debt Load?

Market Cool On Shanghai Medicilon Inc.'s (SHSE:688202) Revenues Pushing Shares 27% Lower

Apr 25
Market Cool On Shanghai Medicilon Inc.'s (SHSE:688202) Revenues Pushing Shares 27% Lower

Financial Position Analysis

Short Term Liabilities: 688202's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥540.1M).

Long Term Liabilities: 688202's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥56.2M).


Debt to Equity History and Analysis

Debt Level: 688202 has more cash than its total debt.

Reducing Debt: 688202's debt to equity ratio has increased from 0% to 11.3% over the past 5 years.

Debt Coverage: 688202's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if 688202's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 02:46
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Medicilon Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yuan Yuan SunIndustrial Securities Co. Ltd.
Tao FuTopsperity Securities